FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010608002> ?p ?o ?g. }

• W3010608002 endingPage "116" @default.
• W3010608002 startingPage "102" @default.
• W3010608002 abstract "Flunixin meglumine (FM) and phenylbutazone (PBZ) are potent anti-inflammatory agents and as such their potential to mask injuries that would otherwise keep a horse from training or racing is concerning. A common practice in racetrack medicine in the USA is to administer the two drugs within close proximity (24 hours apart) of each other, raising the concern of pharmacokinetic interactions and enhanced anti-inflammatory effects.Describe the pharmacokinetics and effects of PBZ on the clearance of FM when administered in close proximity as well as effects on inflammatory mediators.Two-way randomised balanced crossover experiment.Twelve Thoroughbred exercised horses received 500 mg FM IV alone or in combination with 2 g of IV PBZ 24 hours later. Blood and urine samples were collected prior to and for up to 120 hours post-drug administration. Whole blood samples were collected at various times and challenged with lipopolysaccharide or calcium ionophore to induce ex vivo synthesis of eicosanoids. Concentrations of FM, PBZ and eicosanoids were measured using LC-MS/MS and noncompartmental pharmacokinetic analysis performed on concentration data.Flunixin meglumine clearance was significantly increased when horses received PBZ 24 hours post-administration (P = .03). No other differences in pharmacokinetic parameters were noted between groups. Thromboxane B2 was significantly suppressed, relative to baseline for 96 hours post-FM administration. Subsequent administration of PBZ prolonged the suppression. Prostaglandin E2 was decreased for 24 hours following administration of FM with subsequent administration of PBZ prolonging the suppression until 120 hours. PGF2alpha concentrations were decreased for up to 168 hours post-FM administration. FM administration significantly decreased 15-HETE.Small sample size and lack of a phenylbutazone-only treatment group.Administration of PBZ post-FM administration increased FM clearance. The anti-inflammatory effects of FM appear to be prolonged when PBZ is administered 24 hours post-administration." @default.
• W3010608002 created "2020-03-13" @default.
• W3010608002 creator A5010029612 @default.
• W3010608002 creator A5037966353 @default.
• W3010608002 creator A5038428213 @default.
• W3010608002 creator A5043317923 @default.
• W3010608002 creator A5055998311 @default.
• W3010608002 creator A5085232510 @default.
• W3010608002 date "2020-04-17" @default.
• W3010608002 modified "2023-09-23" @default.
• W3010608002 title "Pharmacokinetics and anti‐inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses" @default.
• W3010608002 cites W1409567575 @default.
• W3010608002 cites W1514700116 @default.
• W3010608002 cites W1551354257 @default.
• W3010608002 cites W1986438429 @default.
• W3010608002 cites W1995082781 @default.
• W3010608002 cites W1998650234 @default.
• W3010608002 cites W2000647441 @default.
• W3010608002 cites W2004016651 @default.
• W3010608002 cites W2009949963 @default.
• W3010608002 cites W2013225336 @default.
• W3010608002 cites W2016538350 @default.
• W3010608002 cites W2020092959 @default.
• W3010608002 cites W2032418350 @default.
• W3010608002 cites W2060627555 @default.
• W3010608002 cites W2067674980 @default.
• W3010608002 cites W2073584153 @default.
• W3010608002 cites W2075989451 @default.
• W3010608002 cites W2076534794 @default.
• W3010608002 cites W2095265570 @default.
• W3010608002 cites W2123622799 @default.
• W3010608002 cites W2129935236 @default.
• W3010608002 cites W2142980049 @default.
• W3010608002 cites W2149319043 @default.
• W3010608002 cites W2215257582 @default.
• W3010608002 cites W2291305842 @default.
• W3010608002 cites W2903317380 @default.
• W3010608002 cites W91681715 @default.
• W3010608002 doi "https://doi.org/10.1111/evj.13260" @default.
• W3010608002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32145701" @default.
• W3010608002 hasPublicationYear "2020" @default.
• W3010608002 type Work @default.
• W3010608002 sameAs 3010608002 @default.
• W3010608002 citedByCount "7" @default.
• W3010608002 countsByYear W30106080022021 @default.
• W3010608002 countsByYear W30106080022022 @default.
• W3010608002 countsByYear W30106080022023 @default.
• W3010608002 crossrefType "journal-article" @default.
• W3010608002 hasAuthorship W3010608002A5010029612 @default.
• W3010608002 hasAuthorship W3010608002A5037966353 @default.
• W3010608002 hasAuthorship W3010608002A5038428213 @default.
• W3010608002 hasAuthorship W3010608002A5043317923 @default.
• W3010608002 hasAuthorship W3010608002A5055998311 @default.
• W3010608002 hasAuthorship W3010608002A5085232510 @default.
• W3010608002 hasConcept C112705442 @default.
• W3010608002 hasConcept C142724271 @default.
• W3010608002 hasConcept C151730666 @default.
• W3010608002 hasConcept C204787440 @default.
• W3010608002 hasConcept C27081682 @default.
• W3010608002 hasConcept C2775844104 @default.
• W3010608002 hasConcept C2780762169 @default.
• W3010608002 hasConcept C71924100 @default.
• W3010608002 hasConcept C86803240 @default.
• W3010608002 hasConcept C87813604 @default.
• W3010608002 hasConcept C98274493 @default.
• W3010608002 hasConceptScore W3010608002C112705442 @default.
• W3010608002 hasConceptScore W3010608002C142724271 @default.
• W3010608002 hasConceptScore W3010608002C151730666 @default.
• W3010608002 hasConceptScore W3010608002C204787440 @default.
• W3010608002 hasConceptScore W3010608002C27081682 @default.
• W3010608002 hasConceptScore W3010608002C2775844104 @default.
• W3010608002 hasConceptScore W3010608002C2780762169 @default.
• W3010608002 hasConceptScore W3010608002C71924100 @default.
• W3010608002 hasConceptScore W3010608002C86803240 @default.
• W3010608002 hasConceptScore W3010608002C87813604 @default.
• W3010608002 hasConceptScore W3010608002C98274493 @default.
• W3010608002 hasIssue "1" @default.
• W3010608002 hasLocation W30106080021 @default.
• W3010608002 hasLocation W30106080022 @default.
• W3010608002 hasOpenAccess W3010608002 @default.
• W3010608002 hasPrimaryLocation W30106080021 @default.
• W3010608002 hasRelatedWork W11032860 @default.
• W3010608002 hasRelatedWork W13516814 @default.
• W3010608002 hasRelatedWork W17092653 @default.
• W3010608002 hasRelatedWork W17138094 @default.
• W3010608002 hasRelatedWork W17407089 @default.
• W3010608002 hasRelatedWork W21935811 @default.
• W3010608002 hasRelatedWork W6014000 @default.
• W3010608002 hasRelatedWork W6980686 @default.
• W3010608002 hasRelatedWork W9302247 @default.
• W3010608002 hasRelatedWork W899728 @default.
• W3010608002 hasVolume "53" @default.
• W3010608002 isParatext "false" @default.
• W3010608002 isRetracted "false" @default.
• W3010608002 magId "3010608002" @default.
• W3010608002 workType "article" @default.